Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 5201 Great America Parkway
  • Suite 320
  • Santa Clara, CA 95054

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001396238
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Business Status Development Stage Company a/o
Incorporated In: NY, USA
Year of Inc. 1999
Employees 13 a/o May 12, 2015
Company Officers/Contacts
Simon Chin President, CEO, CFO
Grace Osborne VP, Business Development
James LeBlanc COO
Ralph Sinibaldi VP, Prod. Dev.
Ronald Mark Gemberling CMO
Paul Yaswen CSO
Company Directors
Simon Chin
Douglas Hendren, MD
Grace Osborne
Service Providers
Accounting/Auditing Firm
Fiondella, Milone & LaSaracina LLP
300 Winding Brook Dr
Glastonbury, CT, 06033
United States

Legal Counsel
Sichenzia Ross Ference Kesner LLP
61 Broadway
32nd Floor
New York, NY, 10006
United States

Investor Relations Firm
Not Available
IRSB Security Details
Share Structure
Market Value1 $2,269,283 a/o Sep 22, 2017
Authorized Shares 20,000,000 a/o May 11, 2015
Outstanding Shares 21,368,011 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 5,956,081 a/o Apr 11, 2016
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Philadelphia Stock Transfer, Inc.
Shareholders of Record 70 a/o Apr 11, 2016
Short Selling Data
Short Interest 7 (0%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security